BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15265668)

  • 1. Modulatory effects on myocardial physiology induced by an anti-Trypanosoma cruzi monoclonal antibody involve recognition of major antigenic epitopes from beta1-adrenergic and M2-muscarinic cholinergic receptors without requiring receptor cross-linking.
    Cremaschi G; Fernández MM; Gorelik G; Goin JC; Fossati CA; Zwirner NW; Malchiodi EL
    J Neuroimmunol; 2004 Aug; 153(1-2):99-107. PubMed ID: 15265668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of cardiac physiology by an anti-Trypanosoma cruzi monoclonal antibody after interaction with myocardium.
    Cremaschi G; Zwirner NW; Gorelik G; Malchiodi EL; Chiaramonte MG; Fossati CA; Sterin-Borda L
    FASEB J; 1995 Nov; 9(14):1482-8. PubMed ID: 7589990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies from Trypanosoma cruzi infected mice recognize the second extracellular loop of the beta 1-adrenergic and M2-muscarinic receptors and regulate calcium channels in isolated cardiomyocytes.
    Mijares A; Verdot L; Peineau N; Vray B; Hoebeke J; Argibay J
    Mol Cell Biochem; 1996; 163-164():107-12. PubMed ID: 8974045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and functional analysis of the B cell epitopes recognized by anti-receptor autoantibodies in patients with Chagas' disease.
    Elies R; Ferrari I; Wallukat G; Lebesgue D; Chiale P; Elizari M; Rosenbaum M; Hoebeke J; Levin MJ
    J Immunol; 1996 Nov; 157(9):4203-11. PubMed ID: 8892658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-beta1-adrenergic receptor autoantibodies in patients with chronic Chagas heart disease.
    Labovsky V; Smulski CR; Gómez K; Levy G; Levin MJ
    Clin Exp Immunol; 2007 Jun; 148(3):440-9. PubMed ID: 17419712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal dysfunction in patients with chronic Chagas' disease is associated to anti-Trypanosoma cruzi antibodies that cross-react with rhodopsin.
    Matsumoto SC; Labovsky V; Roncoroni M; Guida MC; Giménez L; Mitelman J; Gori H; Jurgelevicius R; Grillo A; Manfredi P; Levin MJ; Paveto C
    FASEB J; 2006 Mar; 20(3):550-2. PubMed ID: 16423878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of the cross-reaction between an antibody to the Trypanosoma cruzi ribosomal P2beta protein and the human beta1 adrenergic receptor.
    Smulski C; Labovsky V; Levy G; Hontebeyrie M; Hoebeke J; Levin MJ
    FASEB J; 2006 Jul; 20(9):1396-406. PubMed ID: 16816115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional complexity of the humoral response against the Trypanosoma cruzi ribosomal P2 beta protein in patients with chronic Chagas' heart disease.
    Mahler E; Hoebeke J; Levin MJ
    Clin Exp Immunol; 2004 Jun; 136(3):527-34. PubMed ID: 15147356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of anti-M2 and anti-beta1 autoantibodies do not correlate with the degree of heart dysfunction in Chagas' heart disease.
    Talvani A; Rocha MO; Ribeiro AL; Borda E; Sterin-Borda L; Teixeira MM
    Microbes Infect; 2006 Aug; 8(9-10):2459-64. PubMed ID: 16963301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of the complex mAb 17.2 and the C-terminal region of Trypanosoma cruzi P2β protein: implications in cross-reactivity.
    Pizarro JC; Boulot G; Bentley GA; Gómez KA; Hoebeke J; Hontebeyrie M; Levin MJ; Smulski CR
    PLoS Negl Trop Dis; 2011 Nov; 5(11):e1375. PubMed ID: 22069505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The beta1 adrenergic effects of antibodies against the C-terminal end of the ribosomal P2beta protein of Trypanosoma cruzi associate with a specific pattern of epitope recognition.
    Lopez Bergami P; Gómez KA; Levy GV; Grippo V; Baldi A; Levin MJ
    Clin Exp Immunol; 2005 Oct; 142(1):140-7. PubMed ID: 16178868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypanosoma cruzi antigen that interacts with the beta1-adrenergic receptor and modifies myocardial contractile activity.
    Joensen L; Borda E; Kohout T; Perry S; García G; Sterin-Borda L
    Mol Biochem Parasitol; 2003 Apr; 127(2):169-77. PubMed ID: 12672526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human beta 1-adrenergic receptor.
    Ferrari I; Levin MJ; Wallukat G; Elies R; Lebesgue D; Chiale P; Elizari M; Rosenbaum M; Hoebeke J
    J Exp Med; 1995 Jul; 182(1):59-65. PubMed ID: 7790824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of human chagasic IgG with the second extracellular loop of the human heart muscarinic acetylcholine receptor: functional and pathological implications.
    Goin JC; Leiros CP; Borda E; Sterin-Borda L
    FASEB J; 1997 Jan; 11(1):77-83. PubMed ID: 9034169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies bind and activate beta adrenergic and cholinergic lymphocyte receptors in Chagas' disease.
    Gorelik G; Genaro AM; Sterin-Borda L; Gonzalez Cappa S; Borda ES
    Clin Immunol Immunopathol; 1990 May; 55(2):221-36. PubMed ID: 2157570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A lytic monoclonal antibody to Trypanosoma cruzi bloodstream trypomastigotes which recognizes an epitope expressed in tissues affected in Chagas' disease.
    Zwirner NW; Malchiodi EL; Chiaramonte MG; Fossati CA
    Infect Immun; 1994 Jun; 62(6):2483-9. PubMed ID: 7514576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A monoclonal antibody against the immunodominant epitope of the ribosomal P2beta protein of Trypanosoma cruzi interacts with the human beta 1-adrenergic receptor.
    Mahler E; Sepulveda P; Jeannequin O; Liegeard P; Gounon P; Wallukat G; Eftekhari P; Levin MJ; Hoebeke J; Hontebeyrie M
    Eur J Immunol; 2001 Jul; 31(7):2210-6. PubMed ID: 11449375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of circulating anti-muscarinic and anti-adrenergic antibodies and their effect on cardiac arrhythmias and dysautonomia in murine models of Chagas disease.
    Daliry A; Pereira IR; Pereira-Junior PP; Ramos IP; Vilar-Pereira G; Silvares RR; Lannes-Vieira J; Campos De Carvalho AC
    Parasitology; 2014 Nov; 141(13):1769-78. PubMed ID: 25093253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of M(2) muscarinic receptor-receptor interaction by immunoglobulin G antibodies from Chagas' disease patients.
    Beltrame SP; Auger SR; Bilder CR; Waldner CI; Goin JC
    Clin Exp Immunol; 2011 May; 164(2):170-9. PubMed ID: 21391990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trypanosoma cruzi: detection of a surface antigen cross-reactive to human C-reactive protein.
    Melo Coutinho CM; Cavalcanti GH; Bonaldo MC; Mortensen RF; Araújo-Jorge TC
    Exp Parasitol; 1998 Oct; 90(2):143-53. PubMed ID: 9769244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.